Study Stopped
insufficient staff
Breast Reconstruction Following Breast Cancer in Very High Risk Patients
Evaluating Breast Reconstruction Timing and Risk Reduction Strategies in Patients at a Higher Risk for Developing Breast Reconstruction Surgical Complications: A Prospective Randomized Study
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The purpose of this study is to:
- 1.Evaluate whether immediate or delayed reconstruction should be offered for breast reconstruction candidates with higher risk for surgical complications by comparing complications, quality of life, and hospital costs
- 2.Determine the efficacy of risk reduction strategies for breast reconstruction patients with higher risk for surgical complications
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2019
Typical duration for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2017
CompletedFirst Posted
Study publicly available on registry
August 25, 2017
CompletedStudy Start
First participant enrolled
May 31, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedMay 20, 2022
May 1, 2022
3.1 years
July 19, 2017
May 16, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
optimal timing of reconstruction in patients at a higher risk for developing breast reconstruction surgical complications
Proportion of patients preferring delayed reconstruction.
Until 1 year post breast reconstruction
Secondary Outcomes (5)
Major complications
Until 1 year post breast reconstruction
Minor complications
Until 1 year post breast reconstruction
Number of revision surgeries
Until 1 year post breast reconstruction
Hospital cost of the complete reconstruction treatment
Until 1 year post breast reconstruction
Change in patient satisfaction
Until 1 year post breast reconstruction
Other Outcomes (1)
Aesthetic evaluation
Until 1 year post breast reconstruction
Study Arms (2)
Immediate breast reconstruction
ACTIVE COMPARATORThe surgical schedule will follow unaltered standard protocol for immediate reconstruction right after the patient's mastectomy. Patients will complete a quality of life questionnaire (Breast-Q) both pre-operatively and at different time points during the follow up. The patient's chart will be followed from the mastectomy surgery onwards until 1 year post-final reconstructive surgery for determining complications and hospital costs.
Delayed breast reconstruction
EXPERIMENTALPatients will start the reconstruction process after cancer therapy has been completed. Patients will be directed to smoking cessation and weight loss resources such as the Bariatric Institute to most directly facilitate risk reduction goals. Risk scores will be assessed at a plastic surgery appointment every 3 months. Reconstruction will proceed after the cancer treatment has been completed, according to individual patient evaluation. Patients will complete a quality of life questionnaire (Breast-Q) both pre-operatively and after the final reconstruction surgery. The patient's chart will be followed from the mastectomy surgery onwards until 1 year post-final reconstructive surgery for determining complications and hospital costs.
Interventions
Only implant based surgeries will be considered in this study. The patient will be followed for at least 1 year after the last reconstruction surgery. Reconstruction will be attempted immediately after mastectomy.
Risk reduction strategies on smoking, weight, and chronic disease control will be offered. The individual risk will be recalculated every three months. Delayed breast reconstruction will be offered when core cancer therapies (mastectomy, chemotherapy and radiation) are complete. Only implant based surgeries will be considered in this study. The patient will be followed for at least 1 year after the last reconstruction surgery.
Developed out of Memorial Sloan-Kettering Institute for Cancer Research, this questionnaire is designed to create a patient-reported outcome measure to provide quantifiable information about the impact and effectiveness of breast surgery. In this study it will be used for quality of life assessment
Eligibility Criteria
You may qualify if:
- Subjects must have histologically or cytologically confirmed breast cancer or indication for prophylactic mastectomy.
- Subjects must be breast reconstruction candidates using implant based breast reconstruction.
- Subjects must have a pre-operative risk \>20% complication prediction from the Breast Reconstruction Risk Assessment (BRA) Score for implant-based breast reconstruction candidates
- Subjects must have the ability to understand and the willingness to sign a written informed consent document.
You may not qualify if:
- Prior breast cancer surgical treatment
- Prior breast reconstruction
- Inability to provide written consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cleveland Clinic, Case Comprehensive Cancer Center
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Risal Djohan, MD
Cleveland Clinic, Case Comprehensive Cancer Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2017
First Posted
August 25, 2017
Study Start
May 31, 2019
Primary Completion
July 1, 2022
Study Completion
July 1, 2022
Last Updated
May 20, 2022
Record last verified: 2022-05